Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Healius Limited ( (AU:HLS) ) just unveiled an update.
Healius Limited has announced that it will release its HY 2025 results on February 20, 2025, followed by an analyst and investor briefing. This event is significant as it provides insights into the company’s operational performance and its standing in the healthcare industry, potentially impacting stakeholders’ decisions and market positioning.
More about Healius Limited
Healius Limited operates in the healthcare industry, offering a range of medical services and laboratory testing solutions. The company focuses on providing accessible and quality healthcare services across Australia, catering to both public and private sectors.
YTD Price Performance: 3.05%
Average Trading Volume: 2,065
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: €633.6M
Learn more about HLS stock on TipRanks’ Stock Analysis page.
